AMGEN INC Short-Term Debt 2008-2026 | AMGN
Beta
What is short-term debt?
Short-term debt includes borrowings and the current portion of long-term debt due within one year.
What is AMGEN INC's current short-term debt?
AMGEN INC (AMGN) annual short-term debt for 2025 was $4.60B, a 29.55% increase from 2024. AMGEN INC short-term debt for the quarter ending March 31, 2026 was $5.44B.
What was AMGEN INC's short-term debt in 2024?
AMGEN INC annual short-term debt for 2024 was $3.55B, a 146.02% increase from 2023.
What was AMGEN INC's short-term debt in 2023?
AMGEN INC annual short-term debt for 2023 was $1.44B, a 9.30% decline from 2022.
What is AMGEN INC's 5-year short-term debt CAGR?
AMGEN INC short-term debt grew at a compound annual growth rate (CAGR) of 119.14% from FY2020 to FY2025, going from $91.0M to $4.60B over 5 years.
Short-Term Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+119.1%
FY2020
$91.0M
→
FY2025
$4.60B
080910111213141516171819202122232425
5 years selected
Short-Term Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.60B | +29.5% | 10-K |
| FY2024 | $3.55B | +146.0% | 10-K |
| FY2023 | $1.44B | -9.3% | 10-K |
| FY2022 | $1.59B | +1728.7% | 10-K |
| FY2021 | $87.0M | -4.4% | 10-K |
| FY2020 | $91.0M | -96.9% | 10-K |
| FY2019 | $2.95B | -33.2% | 10-K |
| FY2018 | $4.42B | +283.6% | 10-K |
| FY2017 | $1.15B | -73.8% | 10-K |
| FY2016 | $4.40B | +96.0% | 10-K |
| FY2015 | $2.25B | +349.4% | 10-K |
| FY2014 | $500.0M | -80.0% | 10-K |
| FY2013 | $2.50B | +0.4% | 10-K |
| FY2012 | $2.50B | +2870.2% | 10-K |
| FY2011 | $84.0M | -96.6% | 10-K |
| FY2010 | $2.49B | - | 10-K |
| FY2009 | $0 | -100.0% | 10-K |
| FY2008 | $1.00B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →